According to Pfizer (PFE) press office, the company may apply for government approval of its vaccine against Covid-19 in Russia, the Tass agency reported.
Specifically, Pfizer hopes to develop a vaccine distributed to world governments and international organizations, so the sections of the most vulnerable population could get this vaccine according to these recommendations and within a short period after receiving approval from the international organizations and local regulatory authorities. The company is considering applying for approval of the Covid-19 vaccine to the Russian Federation.
Furthermore, the company asserted that Pfizer (PFE) and BioNTech are cooperating to ensure that the vaccine meets a global public health system’s needs.
Earlier yesterday, the Russian news agency Interfax reported that Pfizer would only market its vaccine in countries with signed government-level agreements, and the Russian Federation has yet to sign such agreements.
The pharmaceutical company Pfizer (PFE) announced in another press release that it had invested $120 million in four clinical-stage biotech companies as part of the Pfizer Breakthrough Growth Initiative (PBGI) in the second half of 2020. Pfizer is making a significant commitment to biotechnology companies, as part of PBGI, to provide funding and access to Pfizer’s scientific expertise to help ensure advanced clinical research and development programs will succeed.
A Backdoor Way To Profit From Today’s Crypto Bull Market
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Sponsored
Pfizer Inc. (PFE) shares were reported down -1.56% in trading on Tuesday. At $37.18 per share, Pfizer shares have gained 1.01% year to date. The market capitalization of Pfizer Inc. (PFE) is $206.33 billion at the time of writing. During the past month, the average daily volume for PFE was 40814484 shares, which is lower than its average daily volume over the past year by 25.66, suggesting a greater level of market activity in this company lately.